NCT00364260View on ClinicalTrials.gov

A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.

PHASE3CompletedINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

December 31, 1997

Study Completion Date

August 31, 2003

Conditions

AnemiaKidney FailureLeft Ventricular Hypertrophy

Interventions

DRUG

epoetin alfa

All Listed Sponsors

lead

Janssen-Ortho Inc., Canada

INDUSTRY

NCT00364260 - A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. | Biotech Hunter | Biotech Hunter